facebook-page-view
Advertisement

Sensex, Nifty gain for fourth day as HDFC Bank adds to earnings momentum

By Reuters

  • 20 Jul 2020
Sensex, Nifty gain for fourth day as HDFC Bank adds to earnings momentum
Credit: Reuters

Indian shares ended higher for a fourth straight session on Monday as HDFC Bank's results added to last week's upbeat showing from IT companies, countering the impact of a surge in domestic coronavirus cases past one million.

The NSE Nifty 50 index closed up 1.11% at 11,022.2 and the S&P BSE Sensex ended about 1.08% higher at 37,418.99, led by financial and IT stocks.

India's biggest private-sector lender, HDFC Bank on Saturday reported a 20% rise in first-quarter profit, sending its shares up as much as 4.96%.

Advertisement

The Nifty banking index and the Nifty financials index gained about 1.6% each on optimism from the lender's results. Shadow bank Bajaj Finance rose 4.2%.

HDFC Bank's results followed three IT majors -- Infosys, Wipro and HCL Technologies -- which also reported profits that beat expectations over the last week.

The Nifty IT index ended 2.5% higher and was the top percentage gainer among indexes. Sector heavyweights Infosys, HCL and Wipro all rose over 4%.

Advertisement

Biscuit maker Britannia Industries, which also reported a higher profit for the quarter to June on Friday, advanced 5.34% and topped the gainers among Nifty stocks.

The rally in domestic equities offset worries about a continued surge in India's coronavirus cases that touched 1.1 million by Monday morning, a rise of 40,425 cases over the previous day, according to government data.

Epidemiologists have said the country is still likely months away from hitting its peak.

Advertisement

Among laggards in Mumbai were pharma stocks, with Sun Pharma shedding 3.7% and Cipla dropping 2%, dragging the Nifty Pharma index about 1.5%.

Glenmark Pharmaceuticals dropped as much as 5.8% after local media reported that India's drug regulator had sent a notice to the company on overpricing and false claims of its generic version of favipiravir, FabiFlu.

Advertisement

Share article on

Advertisement
Advertisement